Literature DB >> 23680110

Surrogate endpoints: can size of effect mitigate perplexity?

Francesco Perrone1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23680110     DOI： 10.1016/S1470-2045(13)70196-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Observations on Three Endpoint Properties and Their Relationship to Regulatory Outcomes of European Oncology Marketing Applications.

Authors:  Lawrence Liberti; Pieter Stolk; James Neil McAuslane; Jan Schellens; Alasdair M Breckenridge; Hubert Leufkens
Journal:  Oncologist       Date:  2015-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.